1. Home
  2. GBDC vs ICUI Comparison

GBDC vs ICUI Comparison

Compare GBDC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golub Capital BDC Inc.

GBDC

Golub Capital BDC Inc.

HOLD

Current Price

$12.54

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$153.09

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBDC
ICUI
Founded
2007
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
4.6B
IPO Year
2009
1995

Fundamental Metrics

Financial Performance
Metric
GBDC
ICUI
Price
$12.54
$153.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$14.38
$169.00
AVG Volume (30 Days)
1.2M
184.9K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
11.69%
N/A
EPS Growth
4.41
100.62
EPS
0.29
1.96
Revenue
N/A
$2,231,262,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.46
P/E Ratio
$44.14
$78.02
Revenue Growth
N/A
N/A
52 Week Low
$11.77
$112.50
52 Week High
$14.41
$192.85

Technical Indicators

Market Signals
Indicator
GBDC
ICUI
Relative Strength Index (RSI) 40.85 26.54
Support Level $12.24 $146.59
Resistance Level $13.36 $160.22
Average True Range (ATR) 0.21 4.61
MACD -0.04 -2.03
Stochastic Oscillator 23.33 5.18

Price Performance

Historical Comparison
GBDC
ICUI

About GBDC Golub Capital BDC Inc.

Golub Capital BDC Inc. is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second-lien and subordinated loans, warrants, and minority equity securities in U.S. middle-market companies. The company generally invests in securities rated below investment grade by independent rating agencies, or those that would be rated below investment grade if evaluated. The company operates in the USA, Canada, and other countries, with the majority of its revenue coming from the USA.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: